Advertisement

Topics

Keystone plans clinical testing of 3rd-gen embolic protection device

05:23 EDT 3 Aug 2017 | SmartBrief

Israel-based Keystone Heart said it intends to initiate trials of its TriGuard 3 third-generation cerebral embolic protectio -More

Original Article: Keystone plans clinical testing of 3rd-gen embolic protection device

NEXT ARTICLE

More From BioPortfolio on "Keystone plans clinical testing of 3rd-gen embolic protection device"

Quick Search
Advertisement
 

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...